Integrated Filing — IndAS
General information about company
| Scrip Code |
532843 |
| NSE Symbol |
FORTIS |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE061F01013 |
| Name of company |
FORTIS HEALTHCARE LIMITED |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
22-05-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
15-05-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Fourth quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Audited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
22-05-2026 09:35:00 |
| End date and time of board meeting |
22-05-2026 19:35:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
2,36,467.00 |
9,12,784.00 |
|
Other income |
439.00 |
5,066.00 |
|
Total income |
2,36,906.00 |
9,17,850.00 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
0.00 |
0.00 |
| (b) |
Purchases of stock-in-trade |
52,072.00 |
2,10,865.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(185.00) |
(1,998.00) |
| (d) |
Employee benefit expense |
33,968.00 |
1,29,663.00 |
| (e) |
Finance costs |
8,428.00 |
31,447.00 |
| (f) |
Depreciation, depletion and amortisation expense
|
12,197.00 |
44,943.00 |
| (f) |
Other Expenses |
| 1 |
Professional and consultation fees to doctors |
50,128.00 |
1,94,984.00 |
| 2 |
Other Expenses |
47,251.00 |
1,70,772.00 |
|
Total other expenses |
97,379.00 |
3,65,756.00 |
|
Total expenses |
2,03,859.00 |
7,80,676.00 |
| 3 |
Total profit before exceptional items and tax |
33,047.00 |
1,37,174.00 |
| 4 |
Exceptional items |
(1,249.00) |
(2,224.00) |
| 5 |
Total profit before tax |
31,798.00 |
1,34,950.00 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
6,563.00 |
20,846.00 |
| 8 |
Deferred tax |
(1,262.00) |
9,320.00 |
| 9 |
Total tax expenses |
5,301.00 |
30,166.00 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
26,497.00 |
1,04,784.00 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
622.00 |
1,635.00 |
| 16 |
Total profit (loss) for period |
27,119.00 |
1,06,419.00 |
| 17 |
Other comprehensive income net of taxes |
234.00 |
1,263.00 |
| 18 |
Total Comprehensive Income for the period |
27,353.00 |
1,07,682.00 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
26,585.00 |
1,04,178.00 |
|
Total profit or loss, attributable to non-controlling interests |
534.00 |
2,241.00 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
26,815.00 |
1,05,452.00 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
538.00 |
2,230.00 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
75,496.00 |
75,496.00 |
|
Face value of equity share capital |
10 |
10 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
0.00 |
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
3.52 |
13.8 |
|
Diluted earnings (loss) per share from continuing operations |
3.52 |
13.8 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
3.52 |
13.8 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
3.52 |
13.8 |
| 24 |
Debt equity ratio |
0.3400 |
0.3400 |
| 25 |
Debt service coverage ratio |
1.2400 |
1.8300 |
| 26 |
Interest service coverage ratio |
6.4400 |
6.8400 |
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2025 |
| Date of end of reporting period |
31-03-2026 |
| Whether results are audited or unaudited |
Audited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
5,34,788.00 |
|
Capital work-in-progress |
43,233.00 |
|
Investment property |
1,53,968.00 |
|
Goodwill |
4,72,126.00 |
|
Other intangible assets |
62,108.00 |
|
Intangible assets under development |
201.00 |
|
Biological assets other than bearer plants |
0.00 |
|
Investments accounted for using equity method |
22,515.00 |
|
Non-current financial assets |
|
|
Non-current investments |
12.00 |
|
Trade receivables, non-current |
0.00 |
|
Loans, non-current |
284.00 |
|
Other non-current financial assets |
|
| 1 |
Other financial asset |
8,386.00 |
|
Total of other non-current financial assets |
8,386.00 |
|
Total non-current financial assets |
8,682.00 |
|
Deferred tax assets (net) |
13,339.00 |
|
Other non-current assets |
|
| 1 |
Non current tax assets |
95,611.00 |
| 2 |
Other non-current assets |
8,110.00 |
|
Total of other non-current assets |
1,03,721.00 |
|
Total non-current assets |
14,14,681.00 |
| 2 |
Current assets |
|
|
Inventories |
13,527.00 |
|
Current financial asset |
|
|
Current investments |
1,729.00 |
|
Trade receivables, current |
1,04,376.00 |
|
Cash and cash equivalents |
40,697.00 |
|
Bank balance other than cash and cash equivalents |
13,674.00 |
|
Loans, current |
243.00 |
|
Other current financial assets |
|
|
Total of other current financial assets |
7,696.00 |
|
Total current financial assets |
1,68,415.00 |
|
Current tax assets (net) |
0.00 |
|
Other current assets |
|
|
Total of other current assets |
|
|
Total current assets |
1,81,942.00 |
| 3 |
Non-current assets classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
0.00 |
|
Total assets |
15,96,623.00 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
75,496.00 |
|
Other equity |
9,14,059.00 |
|
Total equity attributable to owners of parent |
9,89,555.00 |
|
Non controlling interest |
27,296.00 |
|
Total equity |
10,16,851.00 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
2,40,116.00 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
0.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
0.00 |
|
Total Trade payable |
0.00 |
|
Other non-current financial liabilities |
|
| 1 |
Lease |
53,633.00 |
|
Total of other non-current financial liabilities |
53,633.00 |
|
Total non-current financial liabilities |
2,93,749.00 |
|
Provisions, non-current |
22,690.00 |
|
Deferred tax liabilities (net) |
51,207.00 |
|
Deferred government grants, Non-current |
|
|
Other non-current liabilities |
|
|
Total of other non-current liabilities |
|
|
Total non-current liabilities |
3,67,646.00 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
47,149.00 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
11,479.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
82,833.00 |
|
Total Trade payable |
94,312.00 |
|
Other current financial liabilities |
|
| 1 |
Lease |
6,360.00 |
| 2 |
Other financial liabilities |
626.00 |
|
Total of other current financial liabilities |
6,986.00 |
|
Total current financial liabilities |
1,48,447.00 |
|
Other current liabilities |
50,988.00 |
| 1 |
Other current liabilities |
16,824.00 |
| 2 |
otherf financial liabilities |
34,164.00 |
|
Total of other current liabilities |
50,988.00 |
|
Provisions, current |
6,324.00 |
|
Current tax liabilities (Net) |
6,367.00 |
|
Deferred government grants, Current |
|
|
Total current liabilities |
2,12,126.00 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
0.00 |
|
Total liabilities |
5,79,772.00 |
|
Total equity and liabilites |
15,96,623.00 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| Date of end of reporting
period |
31-03-2026 |
31-03-2026 |
| Whether results are audited
or unaudited |
Audited |
Audited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
Healthcare |
2,02,323.00 |
7,77,269.00 |
| 2 |
Diagnostics |
38,726.00 |
1,52,656.00 |
| 3 |
Inter Segment |
0.00 |
0.00 |
|
Total Segment Revenue |
2,41,049.00 |
9,29,925.00 |
|
Less: Inter segment revenue |
4,582.00 |
17,141.00 |
|
Revenue from operations |
2,36,467.00 |
9,12,784.00 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
Healthcare |
35,475.00 |
1,39,370.00 |
| 2 |
Diagnostics |
5,561.00 |
24,185.00 |
| 3 |
Inter Segment |
0.00 |
0.00 |
|
Total Profit before tax |
41,036.00 |
1,63,555.00 |
|
i. Finance cost |
8,428.00 |
31,447.00 |
|
ii. Other Unallocable Expenditure net off Unallocable income |
188.00 |
(4,477.00) |
|
Profit before tax |
32,420.00 |
1,36,585.00 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
Healthcare |
12,03,848.00 |
12,03,848.00 |
| 2 |
Diagnostics |
2,09,344.00 |
2,09,344.00 |
| 3 |
Inter Segment |
(4,497.00) |
(4,497.00) |
|
Total Segment Asset |
14,08,695.00 |
14,08,695.00 |
|
Un-allocable Assets |
1,87,928.00 |
1,87,928.00 |
|
Net Segment Asset |
15,96,623.00 |
15,96,623.00 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
Healthcare |
1,88,826.00 |
1,88,826.00 |
| 2 |
Diagnostics |
46,876.00 |
46,876.00 |
| 3 |
Inter Segment |
(4,497.00) |
(4,497.00) |
|
Total Segment Liabilities |
2,31,205.00 |
2,31,205.00 |
|
Un-allocable Liabilities |
3,48,567.00 |
3,48,567.00 |
|
Net Segment Liabilities |
5,79,772.00 |
5,79,772.00 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Items that will not be reclassified to profit and loss |
(338.00) |
(95.00) |
|
Total Amount of items that will not be reclassified to profit and loss |
(338.00) |
(95.00) |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
(62.00) |
(24.00) |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
Items that will be reclassified to profit and loss |
510.00 |
1,334.00 |
|
Total Amount of items that will be reclassified to profit and loss |
510.00 |
1,334.00 |
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
0.00 |
0.00 |
| 5 |
Total Other comprehensive income |
234.00 |
1,263.00 |
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
1,34,950.00 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
31,447.00 |
|
Adjustments for decrease (increase) in inventories |
(1,570.00) |
|
Adjustments for decrease (increase) in trade receivables, current |
(28,074.00) |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
(685.00) |
|
Adjustments for decrease (increase) in other non-current assets |
4,074.00 |
|
Adjustments for other financial assets, non-current |
(9,664.00) |
|
Adjustments for other financial assets, current |
(1,317.00) |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
11,345.00 |
|
Adjustments for increase (decrease) in trade payables, non-current |
3,637.00 |
|
Adjustments for increase (decrease) in other current liabilities |
2,165.00 |
|
Adjustments for increase (decrease) in other non-current liabilities
|
0.00 |
|
Adjustments for depreciation and amortisation expense |
44,943.00 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
(3,294.00) |
|
Adjustments for provisions, current |
424.00 |
|
Adjustments for provisions, non-current |
4,846.00 |
|
Adjustments for other financial liabilities, current |
(3,774.00) |
|
Adjustments for other financial liabilities, non-current |
(1,160.00) |
|
Adjustments for unrealised foreign exchange losses gains |
(21.00) |
|
Adjustments for dividend income |
0.00 |
|
Adjustments for interest income |
3,943.00 |
|
Adjustments for share-based payments |
0.00 |
|
Adjustments for fair value losses (gains) |
0.00 |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
(260.00) |
|
Other adjustments to reconcile profit (loss) |
0.00 |
|
Other adjustments for non-cash items |
3,070.00 |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
52,189.00 |
|
Net cash flows from (used in)
operations |
1,87,139.00 |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
26,994.00 |
|
Other inflows (outflows) of cash |
35.00 |
|
Net cash flows from (used in)
operating activities |
1,60,180.00 |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
0.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
0.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
0.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
1,717.00 |
|
Purchase of property, plant and equipment |
94,553.00 |
|
Proceeds from sales of investment property |
0.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
86,980.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
548.00 |
|
Interest received |
3,948.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
21,479.00 |
|
Net cash flows from (used in)
investing activities |
(1,53,841.00) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
0.00 |
|
Proceeds from issuing shares |
0.00 |
|
Proceeds from issuing other equity instruments |
0.00 |
|
Payments to acquire or redeem entity's shares |
0.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
1,27,096.00 |
|
Repayments of borrowings |
66,771.00 |
|
Payments of lease liabilities |
5,871.00 |
|
Dividends paid |
7,766.00 |
|
Interest paid |
30,312.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
financing activities |
16,376.00 |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
22,715.00 |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
126.00 |
|
Net increase (decrease) in cash
and cash equivalents |
22,841.00 |
|
Cash and cash equivalents cash flow statement at beginning of period
|
9,991.00 |
|
Cash and cash equivalents cash
flow statement at end of period |
32,832.00 |
Details of Impact of Audit Qualification
Amount in (Lakhs)
| Whether results are audited or unaudited |
Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Auditor's opinion |
|
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015:
The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified
opinion for the period on Standalone results |
Yes |
| Sr No. |
Audit firm's name |
Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI |
Certificate valid upto |
| 1 |
BSR & Co. LLP |
Yes |
31-07-2028 |